Filing Details

Accession Number:
0000899243-21-010346
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-08 16:15:19
Reporting Period:
2020-05-08
Accepted Time:
2021-03-08 16:15:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1797336 Ayala Pharmaceuticals Inc. AYLA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277161 David Sidransky 12/15 Moskovitz St.
Rehovot L3 7647412
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-05-08 200 $15.27 200 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-05-12 25 $15.02 225 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-07-07 1 $9.60 226 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-07-17 4 $11.86 230 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-08-14 5 $11.07 235 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-09-11 10 $10.07 245 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-09-14 1 $10.70 246 No 4 P Indirect Held by Reporting Person's son
Common Stock Acquisiton 2020-12-23 4 $11.56 250 No 4 P Indirect Held by Reporting Person's son
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son
No 4 P Indirect Held by Reporting Person's son